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https://doi.org/10.1016/j.stemcr.2018.01.008SUMMARYHuman pluripotent stem cells (hPSCs) hold great promise for understanding kidney development and disease. We reproducibly differ-
entiated three genetically distinct wild-type hPSC lines to kidney precursors that underwent rudimentary morphogenesis in vitro.
They expressed nephron and collecting duct lineage marker genes, several of which are mutated in human kidney disease. Lentiviral-
transduced hPSCs expressing reporter genes differentiated similarly to controls in vitro. Kidney progenitors were subcutaneously
implanted into immunodeficient mice. By 12 weeks, they formed organ-like masses detectable by bioluminescence imaging. Implants
included perfused glomeruli containing human capillaries, podocytes with regions of mature basement membrane, and mesangial cells.
After intravenous injection of fluorescent low-molecular-weight dextran, signal was detected in tubules, demonstrating uptake from
glomerular filtrate. Thus, we have developedmethods to trace hPSC-derived kidney precursors that formed functioning nephrons in vivo.
These advances beyond in vitro culture are critical steps toward using hPSCs to model and treat kidney diseases.INTRODUCTION
The mammalian kidney generates and eliminates waste
products and is essential for life. Annually, 2.6 million
people worldwide receive dialysis or kidney transplanta-
tion for end-stage kidney disease (ESKD), while around
2.2 million people with ESKD die prematurely, unable to
access treatment (Liyanage et al., 2015). Kidney trans-
plants are in short supply and an adult on long-term
dialysis has an average life expectancy of barely a decade
(Neild, 2017). Therapies that prevent the progression of
chronic kidney disease to ESKD are therefore urgently
needed.
The definitive human kidney, the metanephros, initiates
at 5 weeks of gestation (Woolf and Jenkins, 2015) when it is
composed of metanephric mesenchyme (MM) around a
ureteric bud (UB), both derived from intermediate meso-
derm. Over the next month, MM differentiates to form
the first nephrons, each containing a glomerulus in conti-
nuity with proximal and distal tubules. Concurrently, the
UB branches serially to form collecting ducts that fuse
with nascent nephrons. As the glomerulus matures, endo-
thelia invade clusters of podocytes, forming capillary
loops. The adjacent endothelia and epithelia are separated
by the glomerular basement membrane (GBM), and the
three components act as a functional unit that filters blood.Ste
This is an open access artiThe resulting ultrafiltrate is then modified by tubules to
form definitive urine.
Given that kidney disease can result from genetic aberra-
tions (Kerecuk et al., 2008; Hildebrandt, 2010) in utero,
there is an urgent need to better understand the develop-
ment of human kidneys. Although mouse models have
been informative about developmental mechanisms
(Woolf and Davies, 2013; McMahon, 2016), they do not al-
ways exactly phenocopy human kidney diseases that result
from mutations of homologous genes (Woolf and Jenkins,
2015; Kerecuk et al., 2008). Clearly, human models are the
ideal systems for understanding organogenesis in relation
to human health and disease.
The use of expandable human pluripotent stem cells
(hPSCs) with their plasticity in response to developmental
signals is a promising and logical choice for many disease
therapies (Carpenter et al., 2009; Cheng et al., 2014; Ichi-
mura and Shiba, 2017) and for modeling monogenic dis-
eases (Ebert et al., 2009; Shi et al., 2017). This includesmak-
ing kidney cells to model ESKDs, or for therapy. Several
in vitro studies have demonstrated that a defined cocktail
of growth factors and small molecules, applied in a timed
sequence to hPSCs, can result in primitive kidney morpho-
genesis in 2D (Narayanan et al., 2013; Kang andHan, 2014;
Lam et al., 2014; Takasato et al., 2014) and in 3D (Xia et al.,
2014; Takasato et al., 2015; Ciampi et al., 2016) cultures.m Cell Reports j Vol. 10 j 1–14 j March 13, 2018 j ª 2018 The Authors. 1
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allowing interaction between UB andMM tissues and their
co-operative development. This technology is beginning to
show promise to model both genetic (Freedman et al.,
2015) and acquired (Morizane et al., 2015) kidney diseases.
Questions remain, however, regarding the reproducibility
of the differentiation protocols, replicability between
hPSC lines, and the degree of maturity and function that
can be obtained. In 3D transwell formats, kidney structures
progress further giving some regional organization (Taka-
sato et al., 2015), but the kidney progenitors are necessarily
limited in their growth and functional differentiation
because, for example, they lack a blood supply.
With these limitations in mind, we used three wild-
type hPSC lines from different genetic backgrounds and
reproducibly differentiated them into kidney progenitors
in vitro. They underwent rudimentary morphogenesis and
expressed MM/nephron and UB/collecting duct lineage
markers. Using bicistronic lentiviral reporters to trace
the hPSC derivatives in vivo, we showed that the kidney
progenitors formed functional nephrons following subcu-
taneous implantation. Compared with in vitro culture,
hPSC-kidney differentiation was dramatically improved
with the generation of glomeruli, containing human capil-
laries and podocytes separated by regions of mature base-
ment membrane. These are critical advances toward using
hPSCs to model and treat kidney diseases.RESULTS
Gene Expression Patterns in hPSCs Induced to Form
Kidney Precursors in Culture
To obtain kidney progenitor cells for transplantation, we
first determined whether three characterized human em-
bryonic stem cell (hESC) lines, clinical grade MAN13,
MAN11 (Ye et al., 2017; Canham et al., 2015), and HUES1
(Cowan et al., 2004; Oldershaw et al., 2010) had the poten-
tial to differentiate into kidney progenitors using an estab-
lished protocol (Takasato et al., 2014). This comprised
exposure to CHIR99021, a glycogen synthase kinase-3 in-
hibitor, for 3 days before switching to FGF9 and heparin
for 10 days, followed by basal STEMdiff APEL medium
alone until day 30 (Figure 1A). Using qPCR, we docu-
mented the expression of 17 key transcripts characterizing
mesoderm, intermediate mesoderm, MM and its nephron
segment derivatives, and the UB and its collecting duct
derivatives.
In three separate experiments with MAN13, transcripts
for T (Brachyury) andMIXL1, mesodermal/mesendodermal
transcription factors, peaked 1 day into the protocol (Fig-
ure 1B). As these were downregulated, OSR1 and PAX2, in-
termediate mesoderm transcription factor markers, were2 Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018upregulated: PAX2 is also expressed in UB/collecting ducts
and MM, and OSR1 in MM. The expression of both tran-
scripts was maintained during the rest of the in vitro proto-
col with a slight decrease in PAX2 toward day 30. In the first
7–10 days, transcripts for a battery MM/nephron lineage
transcription factors (LHX1, SIX2, WT1, HOXD11, and
SALL1) increased, with an early peak in SALL1 and
HOXD11 and subsequent robust SIX2 andWT1 expression.
Up to day 30, there was a progressive increase in levels of
AQP1, encoding a proximal tubule water channel, with var-
iable upregulation of PODXL, encoding a podocyte sialo-
mucin, between days 10 and 20. Transcripts for PDGFRB,
a marker of pericytes and required for endothelial develop-
ment, increased up to day 20, while those for FOXD1,
a kidney stromal progenitor and endothelial development
marker, increased after day 10. SALL4 and HOXB7, tran-
scription factors of the UB lineage, were induced in the first
week of the protocol, whereas AQP2, which encodes a col-
lecting duct water channel, rose progressively up to day 30.
UMOD transcripts, marking the thick ascending limb of the
loop of Henle, were also detected during differentiation.
Similar patterns of transcript expression were recorded
in HUES1 and MAN11, exposed to this differentiation pro-
tocol (Figure S1). These results suggested reproducibility of
the protocol for obtaining kidney cells from different hESC
lines, and we focused on one, MAN13, for the rest of the
study.
RudimentaryMorphogenesis by hPSC-Derived Kidney
Precursors in 2D Culture
On day 12 of the 2D protocol, cultures comprised
confluent lawns, interspersed with zones of increased cell
density (Figure 2). We immunostained cultures for tran-
scription factors expressed by MM/nephron (WT1, SIX2,
and PAX2) and UB/collecting duct (GATA3 and PAX2) lin-
eages, and for the epithelial adhesion proteinCDH1 (E-cad-
herin). We observed WT1+ cell clusters, some with CDH1+
cores (Figure 2A). In vivo, glomerular podocytes, as well as
induced MM, express WT1 but immunostaining cultures
for the podocyte marker nephrin, and for the distal convo-
luted tubule marker TRPV5, proved negative (data not
shown). SIX2+ cells were mostly detected in loose popula-
tions surrounding CDH1+ structures (Figure 2B), although
we occasionally observed CDH1+/SIX2+ clusters (Fig-
ure 2C), likely representing initial epithelialization within
the MM/nephron lineage. PAX2+ clusters were visualized,
some containing CDH1+ cores (Figure 2D). For GATA3,
two patterns were observed: first, some CDH1+ tubule-
like structures contained subsets of GATA3+ cells (Fig-
ure 2E), consistent with a collecting duct identity; the other
pattern comprised scattered GATA3+ cells around CDH1+
aggregates (Figure 2F), as described in a similar protocol (Ta-
kasato et al., 2015). After 30 days of differentiation in vitro,
Figure 1. Differentiation of MAN13 hPSC to Kidney Lineages in 2D Culture
(A) Schematic of the 30 day differentiation protocol depicting the timing of application of CHIR99021 and FGF9/heparin. The time point of
cell harvest for implantation into mice is also indicated (d12, in red).
(B) qPCR profiling of 17 transcripts at 11 time points over 30 days. The results for three independent experiments are shown in blue, red,
and green, with levels of target transcripts normalized to GAPDH expression. The characteristic tissue/lineage that expresses each gene
in vivo is indicated above the graph for each transcript. The black vertical line in each graph indicates the time of collection of cells for
implantation into mice.
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Figure 2. Immunocytochemistry of hPSC
Cultures
MAN13 cells were differentiated for 12 days
in vitro, when rudimentary morphogenesis
had begun. Cultures were co-stained with
the epithelial cell-cell adhesion protein
CDH1 (left frames) and transcription factors
(middle frames) to detect: MM-derived cells
(WT1 or SIX2); UB-derived tubules (GATA3);
and PAX2, expressed in both lineages.
Right-hand frames show merged images
(red CDH1 and green nuclear proteins).
(A) A WT1+ cell cluster with a central zone
expressing CDH1. (B) Typically, loose SIX2+
cells surrounded CDH1+ zones. (C) Occa-
sionally, subsets of SIX2+ cells appeared to
co-express CDH1. (D) A PAX2+ cluster with
a central zone expressing CDH1. (E) A CDH1+
tubule-like structure containing a subset
of GATA3+ nuclei. (F) In other areas, loosely
packed GATA3+ cells surrounded CDH1+
structures. Scale bars, 40 mm.
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this more advanced stage, SIX2+ cells were present, consis-
tent with potential for further nephrogenesis (Kobayashi
et al., 2008). However, becauseMMandUBprogenitor pop-
ulations were clearly present at day 12, we reasoned that
this would be a suitable point to test their further differen-
tiation after implantation in vivo.
hPSC Differentiation in 3D Organoid Cultures
Aiming to further enhance glomerular morphogenesis we
evaluated alternative protocols. Takasato et al. (2015) differ-4 Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018entiated hESCs for up to a week in 2D culture as above, but
then subjected them to a pulse of CHIR99021, after pellet-
ing and placing at a medium-air interface. We replicated
their formation of 3D organoids with more mature kidney
structures compared with 2D culture (Figure S3), but,
although glomerular structures were formed, they were
immature and not identical to mature glomeruli in vivo. In
particular, glomerular tufts lacked capillaries anddidnot ex-
pressmature collagen IV.We reasoned thatmaturationmay
require more time and factors in the in vivo environment
and set out to evaluate kidney development in vivo.
Figure 3. Transduction of MAN13 hPSCs with a Lentiviral Vector
Expressing a Bicistronic iRFP-E2A-Luciferase Cassette
(A) Diagram of the expression cassette showing the two reporter
genes and the EF1a promoter.
(B) iRFP fluorescence in transduced cells.
(C and D) Viability and cytotoxicity (mean ± SEM, n = 4) in MAN13
cultures transduced with lentivirus (LV-iRFP/Luc), with no signifi-
cant difference compared with untransduced controls (LV-CTRL). As
a positive ‘‘death’’ control, MAN13 cells were treated with 500 nM
staurosporine for 24 hr.
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Reporter Genes
To trace implanted kidney progenitors in vivo, we generated
an integrating lentiviral vector carrying a bicistronic
cassette, expressing a near infrared fluorescent protein
(iRFP, emission at 720 nm) and firefly luciferase, both under
the control of the EF1a promoter (Figure 3A). Transduction
of MAN13 hESCs resulted in robust expression of the fluo-
rescent protein (Figure 3B). Transduction did not affect
viability nor was it toxic (Figures 3C and 3D). Furthermore,
up to day 30 of the in vitro protocol, both the parent and
transduced lines showed similarmorphogenesis (Figure 3E)
and patterns of transcript for T, OSR1, SIX2, PAX2, and
WT1 (Figure 3F).
Assessment of Pluripotency in Lentivirus-Transduced
hESCs by Teratoma Assay
To determine whether lentiviral labeling compromised
the pluripotent potential of hPSCs we subcutaneously im-
planted MAN13 parent hESCs and transduced MAN13
hESCs in the backs of SCID/beige mice as aliquots of one
million cells in Matrigel. Mice were culled when an im-
planted cell mass reached a maximum 1.6 cm across
(Table S1). This protocol led to mice being culled at similar
times (parent line, 38.8 ± 1.2 days; transduced line, 44.6 ±
1.2 days; mean ± SEM; p = 0.07, Student’s t test). Each line
was similarly efficient at forming histologically confirmed
masses (20 out of 24 sites in the parent versus 29 out of
36 in the transduced cells; p = 1.00, Fisher’s exact test,
two-tailed) that were of similar sizes (parent line, 1.13 ±
0.07 cm versus transduced line, 0.98 ± 0.07 cm; p = 0.11,
Student’s t test). Histology revealed that allmasses had hall-
marks of teratomas (Figure S4A), containing endodermal
(Figure S4B), mesodermal (Figure S4C), and ectodermal
(Figure S4D) derivatives. Teratomas formed from lenti-
virus-labeled cells were detectable using bioluminescent
imaging of living mice (Figure S4E), and expressed lucif-
erase (Figure S4F) and human mitochondrial antigen (Fig-
ure S4G), confirming their hESC origin.
Subcutaneous Implantation of Kidney Progenitor
Cells Derived from Labeled hPSCs
Since lentiviral labeling of MAN13 hPSCs had no detri-
mental effect on hESC pluripotency, self-renewal, or differ-
entiation to kidney progenitors in 2D culture, we reasoned(E) Examples of transduced and untransduced differentiating
MAN13 cultures assessed by immunocytochemistry for SIX2, WT1,
and CDH1.
(F) Similar qPCR profiles of transduced versus parent cells during 2D
kidney differentiation. A representative experiment of three inde-
pendent biological repeats is shown for each line.
Scale bars, 200 mm in (B) and 90 mm in (E).
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Figure 4. Subcutaneous Implantation
into beige/SCID Mice of Luciferase-
Labeled MAN13-Derived Kidney Precursor
Cells Harvested at Day 12 in 2D Culture
(A–D) Histological overview 12 weeks after
transplantation. The implanted cells have
formed a differentiated mass (A). Boxed
areas indicate the following: (B) differenti-
ated nephrons; (C) cartilage; and (D) poorly
differentiated tubules and stroma.
(E) Side and dorsal views showing biolumi-
nescence in a living mouse that had received
kidney precursor transplants 12 weeks
previously.
(F) Immunostaining (brown) for luciferase in
area containing nephron-like structures.
(G) Immunostaining (brown) for human
mitochondria, arrows indicate tubules.
Sections in (F) and (G) are not counter-
stained. Scale bars, 100 mm (A) and 50 mm in
(B)–(D), (F), and (G).
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would be suitable for further differentiation in vivo. Based
on our in vitro data, we reasoned that progenitors on day
12 of 2D differentiation would be committed to kidney lin-
eages but still able to respond in the in vivo environment,
while having lost the potential to form teratomas. There-
fore, on day 12, lentivirus-labeled MAN13-derived kidney
progenitors were injected subcutaneously into SCID/beige
mice, as for hESCs. Mice were followed for up to 12 weeks,
at which time nomouse had an implant site with a cellular
mass of 1.6 cm. In fact, masses were only rarely detected on
external inspection and palpation, leading to harvesting at
84.3 ± 0.2 days (Table S1), significantly longer (p < 0.001,
Student’s t test) than for the hESC implants. Only 9 of 32
implant sites contained histologically identified masses,
significantly fewer than for undifferentiated hESC im-
plants (p < 0.001, Fisher’s exact test, two-tailed). Moreover,
these masses were an average diameter of 0.61 ± 0.11 cm,
significantly smaller (p < 0.05, Student’s t test) than for
hESC-derived teratomas.
Histology of tissues generated from transplantedMAN13
kidney precursors (Figure 4A) was strikingly different
from that of teratomas. The kidney precursor implants6 Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018comprised differentiated kidney structures with glomeruli
and tubules (Figure 4B), as well as occasional islands of
cartilage (Figure 4C) and poorly differentiatedmetanephric
tissues (Figure 4D). The masses detected at autopsy corre-
sponded to the bioluminescent areas detected in living
mice using non-invasive imaging (Figure 4E), and reacted
with antibodies to luciferase (Figure 4F) and human mito-
chondrial antigen (Figure 4G) in sections, confirming
that they were composed of human cells. There was some
variation in the degree of differentiation between implants:
for example, the mass in Figure S5 contained prominent
zones in which isolated glomeruli were surrounded by
mesenchyme-like cells and primitive tubules. From
comprehensive histological analysis, of all nine masses
derived from implanted kidney progenitors, we concluded
that teratomas were not generated and that the cells were
able to survive and continue to differentiate to kidney
tissue.
Next, we implanted a second group of mice withMAN13
cells, some differentiated for 12 days, and others for
19 days, using the in vitro 2D protocol. The day 12 implants
formed glomeruli and tubules, similar to those in the first
study, above, at 7/20 injected sites. Although not visible
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masses observed by luminescence in a similar proportion
8/20, injected sites at 12 weeks after implantation
(Table S1). These exhibited an immature morphology (Fig-
ure S6) compared with those generated from day 12 pro-
genitors. This suggests there is likely to be a critical stage
of kidney differentiation in culture beyond which dissoci-
ated cells lose their plasticity and ability to respond to an
in vivo environment, or to each other and undergo only
limited nephrogenesis.
Detailed Phenotyping of Implant Tissues from
hPSC-Derived Kidney Precursor Cells
Next, we characterized the kidney structures formedwithin
the implants. Glomeruli contained red blood cells in their
tufts, consistent with a blood supply, and Bowman spaces
were observed continuous with tubules (Figure 5A).
Glomeruli were immunoreactive with antibodies raised
against the mature GBM proteins, collagen a-3 (IV) and
laminin b2, and to anti-pan-collagen IV, which was also
reactive with basement membranes of nearby tubules (Fig-
ures 5B–5D). Podocyte-like cells in glomerular tufts were
detectedwith antibodies to synaptopodin,WT1, and podo-
calyxin (Figures 5E–5G). Podocin (Figure 5H) and nephrin
(Figure 5I), podocyte slit diaphragm proteins, were promi-
nent on the basal aspect of podocytes. Platelet-derived
growth factor receptor B staining was present in the center
of the glomerular tuft where mesangial cells reside (Fig-
ure 5J). Mesangial-like cells were apparent in this location
by transmission electron microscopy (TEM) (Figure 5K
and Movie S1). Ki67, was rarely detected in glomeruli,
but proliferative cells were prominent in nearby less differ-
entiated areas (Figure 5L).
An antibody against a human PECAM epitope revealed
networks of capillaries within tufts of the majority of
glomeruli (Figure 5M). We also detected larger, arteriole-
like, vessels near glomeruli within the implant. Using dou-
ble immunostaining, luciferase-expressing rhomboidal
pericyte-like cells were closely associated with PECAM+
endothelia in these vessels (Figure 5N). In addition, glomer-
ular podocytes were positive for the vascular growth factor
VEGFA (Figure 5O). Notably, the PECAM antibody did not
react withmouse kidney sections (Figure 5P). Thus implant
glomeruli are vascularized, and endothelia in the glomer-
ular tufts, and vessels around the glomeruli, can derive
from implanted human cells. Moreover, the day 12 kidney
precursor-derived tissues in vivo are morphologically and
molecularly substantially more mature than those formed
in 3D organoid cultures (compare Figure 5 with Figure S3).
In vivo, the glomeruli expressed all the markers tested and,
crucially, they were vascularized in a pattern similar to
native glomeruli in vivo, unlike in the in vitro 3D organoid
cultures.TEM revealed that glomeruli in implants possessed a
characteristic arrangement of podocytes on the outer sur-
face of blood capillaries (Figure 6A). Those capillaries often
contained red blood cells, providing further evidence that
the glomeruli are connected to the blood supply of the
host. Higher-power TEM images of podocyte-capillary in-
terfaces revealed that some had an ultrastructure indistin-
guishable from that seen in mature glomeruli (Figure 6B),
with podocytes possessing the characteristic foot processes
joined by slit diaphragm-like structures and urinary spaces
visible under the foot processes (Figure 6C). Also present
was a fused GBM (Figure 6C). Other areas, showed a less-
mature GBM, sometimes double layered with two lamina
rarae (Figure 6D), as occurs in glomerulogenesis (Sariola,
1984). Implant tissues also contained tubules, some being
positive for nephron-segment markers: cubulin (Figure 7A)
and aquaporin 1 (Figure 7B) in proximal-like tubules, uro-
modulin in thick ascending loops of Henle (Figure 7C),
and TRPV5 in distal convoluted-like tubules (Figure 7D).
Larger-diameter branching tubules expressed CDH1 (Fig-
ure 7E), and others GATA3, suggesting that they were
collecting ducts (Figure 7F). TEM revealed microvilli and
primary cilia in the tubules (Figures 7H and 7I).
Since human glomeruli with patent, perfused capillary
loops were present, we investigated whether glomerular
filtration might be occurring, using day 12 kidney precur-
sor cells with tissue harvested after 11 weeks. Some mice
were intravenously administered fluorescein isothiocya-
nate-labeled 10 kDa dextran 1 hr prior to culling, as this
is filtered by glomeruli and then reclaimed by proximal
tubules (Woolf et al., 1990). Histology revealed a subset
of tubules with fluorescence, most marked in the apical
zone (Figure 7J), with negligible background fluorescence
in uninjected mouse implants (Figure 7K).DISCUSSION
In this study, we have demonstrated that different hPSC
lines can be reproducibly induced to form kidney precur-
sors in vitro, which can further develop in vivo to generate
mature kidney structures, with vascularized glomeruli
that can filter blood to make ultrafiltrate that is processed
by adjacent tubules.
Variation in outcome between lines and protocols has
been an issue with protocols for obtaining PSC kidney cells
in culture. We showed that three wild-type hESC lines
exhibited consistent differentiation in 2D culture, despite
different genetic backgrounds (Ye et al., 2017). Further-
more, we labeled hPSCs with reporter genes for lineage
tracing without compromising their differentiation poten-
tial, allowing hESC-derived kidney progenitor cells to be
traced using non-invasive bioluminescence imaging afterStem Cell Reports j Vol. 10 j 1–14 j March 13, 2018 7
Figure 5. Histology of Glomeruli Gener-
ated from Implanted Luciferase-Labeled
MAN13-Derived Kidney Precursor Cells
Harvested at Day 12 of 2D Culture
Images in (A)–(O) are implants, whereas (P)
is an adult mouse glomerulus. (A) and (I)
were counterstained with H&E; (B), (C),
(M), and (P) were counterstained with he-
matoxylin only; other sections were not
counterstained. All frames are bright-field
views apart from (K), which is TEM and (N),
which is epifluorescence. g indicates a
glomerulus, t indicates a tubule, p indicates
a podocyte, and m indicates a mesangial
cell.
(A) Glomerulus with red blood cells in its
tuft. Note the lumen of the tubule in con-
tinuity with the Bowman space of the
glomerulus.
(B) Collagen a-3 (IV) immunostaining
(brown) in a GBM-like pattern.
(C) Pan-collagen IV immunostaining
(brown) in a glomerulus and nearby tubules.
(D) Laminin B2 (brown) immunostaining in
two glomeruli but negligible in the tubule.
(E) Synaptopodin IHC (brown) in a linear
pattern on the basal aspect of the
podocytes.
(F) WT1 IHC (brown) in podocyte nuclei.
(G) Podocalyxin IHC (brown) in podocytes.
(H) Podocin immunostaining (brown) in a
linear pattern at the basal side of podocytes
(arrows indicate apical sides of podocytes).
(I) Nephrin immunostaining (brown) in a
glomerulus. The boxed area is enlarged on
the top right corner of the frame: arrows
indicate nephrin in a linear pattern adja-
cent to a capillary loop containing a red
blood cell.
(J) Platelet-derived growth factor receptor B
(PDGFRB) IHC (brown) in the center of a
glomerular tuft where mesangial cells reside (boxed area). Arrows indicate additional immunostaining in Bowman capsule.
(K) TEM of a similar area as depicted by a box in (J). m marks a mesangial-like cell and p indicates podocytes.
(L) Ki67 immunostaining (brown) marking proliferation in more poorly differentiated cells near a glomerulus and a tubule; occasional
positive nuclei (arrows) were detected in tubules and Bowman capsules.
(M) PECAM immunostaining (brown) shows an extensive capillary network in glomerular tufts.
(N) PECAM (red) and luciferase (green) double immunostaining. The white asterisk marks the lumen of a small artery that is continuous
with the capillary network in the glomerular tuft; the white dotted line marks the Bowman capsule. Note that luciferase-expressing cells
are closely associated with endothelia whose luminal surface is positive for PECAM.
(O) VEGFA immunostaining (brown) was prominent in podocytes (arrows).
(P) Mouse glomerulus is not reactive with the anti-human PECAM monoclonal antibody.
Scale bars, 50 mm in (A)–(J) and (L)–(P) and 500 nm in (K).
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nephrons.
As shown here and previously (Takasato et al., 2015),
3D transmembrane organotypic cultures can modestly8 Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018advance kidney morphogenesis from PSCs beyond 2D cul-
tures. However, by implanting differentiating cells from 2D
cultures in vivowe have substantially improved their matu-
rity. Implanted progenitors survived subcutaneously for
Figure 6. TEM of a Glomerulus Generated
from Implanted MAN13-Derived Kidney
Precursor Cells
(A) TEM overview of a capillary lumen (CL)
containing a red blood cell (RBC) and lined
by endothelial cells (E). Podocyte-like cells
(PC) and endothelia abut a shared basement
membrane (white arrows).
(B) Diagram of ultrastructure of a mature
glomerulus showing the spatial relation-
ships between the capillary lumen (CL, red),
endothelial cells (E, light blue), and podo-
cytes (PN, dark blue, is a podocyte nucleus,
and PC, green, is podocyte cytoplasm).
Endothelia and podocytes rest on a shared
trilaminar GBM, with the central lamina
densa (black) flanked by the lamina rara
interna on the endothelial side and lamina
rara externa on the podocyte side (both
light grey). Yellow arrows indicate electron
dense slit diaphragm like structures joining
podocyte foot processes that abut the GBM. Asterisks indicate spaces between the foot processes that receive glomerular ultrafiltrate.
(C) High-power TEM showing mature organization of trilaminar GBM (between white arrowheads) and dark slit diaphragm-like structures
(yellow arrowheads) between podocyte foot processes. Asterisks indicate urinary spaces between foot processes.
(D) TEM of another zone showing a less mature appearance. This GBM has two dark lamina densae (white arrow), as occurs in nascent
glomeruli.
Scale bars, 1 mm in (A), 200 nm in (C), and 500 nm in (D).
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tures than reported previously. Notably, mature vascular-
ized glomeruli were observed. Evidence for the maturity
of these glomeruli comes from the observations that they
expressed mature GBM proteins, laminin b2 and collagen
a-3 (IV) (St John et al., 2001), with a fused trilaminar struc-
ture, as well as podocyte processes and slit diaphragms.
Type IV collagen is an essential BM component and forms
three distinct networks from combinations of six different
a chains. Networks formed from trimers of a1,1,2 predom-
inate in early mouse glomerular development, and there
is an isoform switch to the a 3,4,5 network, which is
most abundant inmature GBM (Harvey et al., 1998). Using
a chain-specific antibodies we detected collagen a-3 (IV) in
implant glomeruli indicative of assembly of the mature
a 3,4,5 network. The detection and distribution of both po-
docin and nephrin at the basal aspect of podocytes within
differentiated implants supports the conclusion that slit di-
aphragms were maturing within these glomeruli. Further-
more, the functionality of PSC-derived whole nephrons
has been demonstrated in vivo: we detected uptake by
tubule cells of low MW, filterable, fluorescent dextran
injected into the host circulation. This level of maturity is
remarkable given that the progenitor cells were implanted
at an ectopic site, showing that PSC kidney development,
such as embryonic/fetal kidney development, exhibits a
high level of autonomy. This may be an advantage forfuture use of PSC kidney progenitors therapeutically,
since they require limited instructive signaling from their
environment in order to develop and may be more likely
to develop and function normally in a suboptimal
environment.
A key event in glomerulogenesis, prerequisite for delivery
of blood for filtration, is invasion of the glomerular tuft by
endothelia that form capillary loops. We observed organo-
ids rich in glomeruli with WT1+ tufts in hPSC-derived kid-
ney precursors maintained in 3D organ culture. Although
interstitial spaces around the glomeruli contained PECAM+
cells, endothelia were rarely detected in glomerular tufts,
consistent with the observations of Takasato et al. (2015).
In contrast, we found that glomeruli formed after subcu-
taneous implantation of hESC-derived kidney precursors,
had prominent capillaries, some containing red blood cells,
consistent with perfusion. The human origin for PECAM+
glomerular capillaries in implants was confirmed by reac-
tivity with the human-specific PECAM antibody, not seen
in mouse kidney. We cannot exclude the possibility that
a proportion of endothelia within implants originate
from the host, and indeed connections between the two
vasculatures must exist for perfusion to take place. We
found that the glomeruli that formed in 3D organ culture
had only diffuse low expression of VEGFA, whereas
prominent immunostaining was detected in podocytes of
glomeruli formed by implanted cells, supporting theStem Cell Reports j Vol. 10 j 1–14 j March 13, 2018 9
Figure 7. Tubules Formed from Im-
planted MAN13-Derived Kidney Pre-
cursor Cells and Evidence of Nephron
Functionality
(A)–(G) show bright-field IHC, with (B),
(C), (D), and (F) counterstained with he-
matoxylin. (H) and (I) are TEM images. (J)
and (K) are epifluorescence imaging.
(A) Brush border-like immunostaining
(brown) with antibody to cubulin, a prox-
imal tubule protein, in a subset of tubules.
A negative tubule is marked with a red
asterisk.
(B) Aquaporin 1 immunostaining (brown) in
a subset of tubules; another (asterisk) is
negative. Note, as expected, aquaporin 1 is
also present in glomerular and interstitial
capillaries.
(C) Immunostaining for uromodulin (brown),
a protein in thick ascending limbs of loops of
Henle.
(D) Immunostaining for TRPV5 (brown), a
protein thatmarks distal convoluted tubules;
another tubule (asterisk) and glomeruli are
negative.
(E) CDH1 immunostaining (brown) in large
branched tubules.
(F) GATA3 immunostaining (brown) in a
large tubule; the smaller tubule (asterisk) is
negative.
(G) Negative control: rabbit secondary
antibody applied but primary antibody
omitted.
(H) Overview TEM image of a cross-section
of a tubule, outlined in red dashes.
(I) High-power TEM of central zone of tu-
bules showing a primary cilium (red arrow);
above its basal body is a zone with cross-
sections of a cluster of microvillus-like
structures.
(J) Section from a kidney progenitor-derived mass harvested from a mouse intravenously injected with low-molecular-weight, fluorescein
isothiocyanate (FITC)-labeled dextran. White dashes surround a cross-section of a tubule containing green fluorescence, most marked in
its apical, central, zone. The yellow arrow indicates a small blood vessel that itself contains injected FITC-dextran.
(K) An equivalent section from an implant in a mouse not injected with FITC-dextran shows background green fluorescence only.
Scale bars, 50 mm in (A)–(G) and (J)–(K), 5 mm in (H), and 0.5 mm in (I).
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ular maturation (Tufro´, 2000; Eremina et al., 2003).
Notably, glomeruli formed from implants also contained
mesangial-like cells which provide mechanical integrity
to capillary loops in vivo.
The key function of the kidney is to filter blood, gener-
ating an ultrafiltrate that is modified by tubules to form
definitive urine. Our implants established the essential
components for filtration: blood-perfused capillaries, po-
docytes, and regions of mature GBM between these cells.10 Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018After intravenous injection of fluorescently labeled low-
MW dextran glomerular filtration followed by tubule
uptake of fluorescent dextran in a subset of PSC kidney
tubules was observed. Others have transplanted intact hu-
man embryonicmetanephric kidneys, but not PSC-derived
kidney tissue, into immunodeficient mice where they
differentiated into urine producing kidneys (Dekel et al.,
2002, 2003). Other studies have also attempted to generate
functional glomeruli from human SCs. Xinaris et al. (2016)
mixed human amniotic SCs with mouse metanephric
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these into mice: human cells contributed to the formation
of some functional glomeruli, assessed by the uptake of
infused BSA. Using hPSCs carrying a podocyte-specific pro-
moter-reporter gene, Sharmin et al. (2016) generated podo-
cytes and mixed them with a human endothelial cell line.
After transplanting the mixture under the kidney capsule,
they reported the presence of vascularized glomeruli con-
taining donor-derived podocytes. In neither study did a
whole kidney-like organ form from a single source of hu-
man cells, as we have demonstrated for hPSCs.
The technological advances we have generated will facil-
itate use of hPSC-derived kidney tissues as models of ge-
netic human disease. As the hPSCs differentiate toward
kidney progenitors in vitro, they expressed the transcrip-
tion factors PAX2 and SALL1, respectively mutated in the
human renal coloboma (Sanyanusin et al., 1995) and
Townes-Brocks (Faguer et al., 2009) syndromes featuring
kidney malformations. We show that glomerular proteins
that can be mutated in blood filtration diseases were pre-
sent in implant glomeruli. These genetic diseases include
congenital nephrotic syndrome (nephrin and podicin;
Hildebrandt, 2010), Alport syndrome (collagen genes,
including COL4A3; Lemmink et al., 1994), Pierson syn-
drome (LAMB2; Zenker et al., 2004), and Frasier syndrome
(WT1; Barbaux et al., 1995). Other proteins essential for ter-
minal differentiation of kidney tubules were also expressed
in the implants: cubulin present in the apical brush border
of proximal tubules, where it functions withmegalin in up-
take of small proteins; uromodulin, an apical protein in
ascending loops of Henle and mutated in medullary cystic
kidney disease (Ovunc et al., 2011; Turner et al., 2003);
and TRPV5, involved in calcium transport in the distal
convoluted tubule. Combining our current technology
with CRISPR/Cas9 gene editing of hPSCs (Freedman
et al., 2015) with mutation generation, or correction of
(patient-derived) mutations and evaluation of implanted
kidney tissues in vivo will provide much improved insight
into disease mechanisms and allow more focused drug
discovery.
Numerous limitations will need to be overcome before a
whole functional renal tract can be generated from hPSCs.
First, the mammalian kidney receives 20% of the cardiac
output, to generate the requiredhighbloodflowandhydro-
static pressures within glomerular capillaries, which facili-
tate glomerular ultrafiltration. Although PSC-kidney pre-
cursor cells-derived tissues lack large arteries, in future,
placing transplanted cells near arterio-venous loops may
enhance the blood supply, as used in transplantation of,
e.g., embryonic liver (Fiegel et al., 2010). Second, although
the kidney-like tissues that formed contained numerous
nephrons, branched collecting ducts were sparse. In future,
modulation of in vitro protocols to enhance the UB/collect-ing duct lineage (Taguchi et al., 2014) could be employed.
Our study has also gone some way to demonstrating the
safety of implanting kidney progenitors in vivo: none of
the implants showed typical teratoma three-germ-layer dif-
ferentiation. This is promising for the prospect of using
these cells to generate human kidney repair in the future,
although many challenges remain including development
and survival in a hostile, damaged kidney environment.
Evaluation up to a year after transplantation,will be needed
to determine the longer-term fates of the cells. Finally, a
functional kidney needs to deliver urine into a lower uri-
nary tract. No structures were formed thatmorphologically
resembled either the renal pelvis or the ureter and immuno-
staining for the urothelial marker uroplakin II was negative
(data not shown). In future, therefore, it may be necessary
to fuse a host ureter with the kidney tubules that form after
implantation of PSC-derived kidney precursors, thus form-
ing a single functional renal tract.
Although there is still room for improvement in the dif-
ferentiation and maturation efficiency, we have provided
proof-of-principle that, when hPSC-derived kidney pro-
genitors are implanted in vivo, they can produce more
mature kidney structures than in 2D or 3D culture, with
near normal patterns of glomerular vascularization. We
have generated functional nephrons from hPSCs and
shown that their glomeruli are molecularly and ultrastruc-
turally mature. This work greatly advances our progress
toward using stem cells for kidney repair and as tools to
investigate human genetic diseases affecting the kidney.EXPERIMENTAL PROCEDURES
hPSC Culture and Differentiation
hESC lines, MAN11 and MAN13 (Ye et al., 2017) and HUES1, kind
gift from Cowan et al. (2004), were cultured in our feeder-free
system modified from that described previously (Baxter et al.,
2009). MAN11 and MAN13 were cultured on human Vitronectin
(rhVTN-N, Life Technologies, no. A14700) and HUES1 onMatrigel
(BD Biosciences, no. 734–1440) substrates, in mTeSR1 or TeSR2
medium (STEMCELL Technologies, nos. 8850 and 5860). Cell dif-
ferentiation to kidney in 2D cultureswas performed as described in
Takasato et al. (2014), with a starting cell density of 18,000 cm2,
while differentiation in 3D cultures was modified from Takasato
et al. (2015). For a detailed description of stem cell culture and
differentiation protocols, see Supplemental Information.
Lentiviral Vector Production and Transduction
of hESCs
Construction of the lentiviral shuttle plasmid pRRL.sin.cppt.EF1a-
iRFP-E2A-Luc, expressing iRFP and luciferase under the control of
the EF1a promoter is described in Supplemental Information.
Third-generation lentiviral vectors were constructed as described
previously (Dajas-Bailador et al. (2014) and Supplemental Informa-
tion). HESCs were transduced at an MOI of 5 IU/cell.Stem Cell Reports j Vol. 10 j 1–14 j March 13, 2018 11
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RNA samples from cultures were collected at 0, 1, 3, 5, 7, 10, 13, 16,
19, 24, and 30 days after initiation of differentiation. RNA was ex-
tracted using the miRVana miRNA isolation kit (Thermo Fisher,
AM1560) according to the manufacturer’s instructions. Real-time
qPCR was performed using the TaqMan RNA-to-Ct 1-Step Kit
(Thermo Fisher, 4392653) according to themanufacturer’s instruc-
tions, on a Bio-Rad C1000 Thermal Cycler fit with a CFX384 Real
Time System, using 15 ng of RNA per reaction. The primers used
are shown in Table S2.
Immunostaining of Cultures and Viability/Toxicity
Assays
See Supplemental Information and Table S3.
Implantation of hPSCs and Kidney Progenitor Cells
into Immunocompromised Mice
All surgery was carried out under UK Home Office Licence (70/
7838) obtained after local ethics committee approval. SCID/beige
mice were injected subcutaneously at four sites each, with
MAN13 hESCs (1.03 106 cells/site) or MAN13-derived kidney pro-
genitors (day 12 or 19 of the differentiation protocol; 3.0 3 106
cells/site). The cells had been previously resuspended in a 2:1
mix of DMEM-F12:Matrigel (see Supplemental Information).




Supplemental Information includes Supplemental Experimental
Procedures, six figures, three tables, and one movie and can be
found with this article online at https://doi.org/10.1016/j.stemcr.
2018.01.008.
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SUPPLEMENTAL FIGURE LEGENDS 
 
Figure S1. (Related to Figure 1). QPCR profiling of HUES1 and MAN11 hPSCs differentiating in the 2D 
kidney protocol. Cells were differentiated for 19 days and expression of 17 species of transcripts, normalised 
against GAPDH, was assessed. Biological repeats for HUES1 cells are shown in blue and red.  
 
Figure S2. (Related to Figure 2). Immunocytochemistry of hPSC derivatives after 30 days of 2D culture. 
Note clusters of nephron progenitors (WT1
+











 cells between these clusters. Bar is 40 μm. 
 
Figure S3. (Related to Figure 2). Analyses of hPSC-derived kidney cells in 3D cultures. A. Phase contrast 
image of the edge of an organoid at the end of the culture period (d25). Note the complex internal structure.  B-
K. Histology sections of organoids, with blue haematoxylin nuclei counterstain in B and J. B. IHC for collagen 
alpha-3 (IV) shows only background (unspecific signal). C. IHC for pan-collagen IV shows positive signals 
(brown) in glomeruli and tubules. D. IHC for laminin B2 shows positive signals (brown) in glomerulus but not 
in an adjacent tubule. E. IHC for synaptopodin shows positive cells in glomerular tufts. F. Cells in glomerular 
tufts immunostain for WT1. G. Glomerular cells positive for podocalyxin IHC. H. IHC for Ki67 detects 
proliferating cells in the interstitium between a glomerulus and a tubule. I. Lack of background signal with anti-
rabbit secondary antibody and omission of primary antibody. J. PECAM IHC detected capillary-like structures 
(red asterisk) in the insterstitium near a glomerulus, and around the glomerular capsule, but the glomerular tuft 
itself is negative. K. No significant signal when immunostaining for VEGFA. g: glomerular-like structures and 
t: tubules. Bars are 20 μm in A and 50 μm in other frames.  
 
Figure S4. (Related to Figures 3 and 4). Subcutaneous implantation into beige/SCID mice of luciferase 
labelled MAN13 hPSCs. A. Histological overview of teratoma four weeks after implantation stained with 
haematoxylin and eosin. The teratoma contains a variety of tissues from the three primary embryonic germ 
layers. The boxed areas indicate: B. gland-like endoderm; C. muscle mesoderm; and D. neuro-epithelial-like 
ectoderm. E. Luciferase-labelled implanted cells were detected in living animals four weeks after implantation 
after luciferin injection and non-invasive imaging by their bioluminescence; dorsal and side views are shown. F. 
Immunostaining of teratomas (brown) for luciferase. G. Immunostaining (brown) for human mitochondria. Note 
that sections in F. and G. are not counterstained. Scale bars: A, 500 μm; B, C, D, F and G 50 μm. 
 
Figure S5. (Related to Figure 4). A kidney-like structure grown from subcutaneously implanted MAN13-
derived kidney precursor cells harvested at day 12 in 2D culture. A-D were counterstained with 
haematoxylin and eosin, while E-G were not counterstained. A. Compared with that depicted in Figure 6, this 
implant appeared less differentiated. B-D. Despite clusters of glomeruli and tubules (B), other areas contained 
cartilage (C) or zones of glomeruli surrounded by mesenchyme-like cells and primitive tubules (D). E-G. 
Within the latter zone, tubules expressed CDH1 (brown in E), both tubules (dotted outlines) and mesenchyme 
were rich in Ki67 expressing cells (brown in F), and tubules immunostained weakly for PAX2 (brown in G). 
Scale bars: A, 100 μm; B-G, 50 μm. 
 
Figure S6. (Related to Figure 4). Subcutaneous implantation into beige/SCID mice of luciferase-labelled 
MAN13-derived kidney precursor cells harvested at day 19 in 2D culture. A. Overview. B and C. Primitive 
nephrons. D. Undifferentiated mesenchyme-like cells. Compare this tissue mass that contains only very 
primitive nephrons and tubules with tissues resulting from day 12 implants (see Figure 6). Bars are 100 μm in A 
and 50 μm in B-D. 
 
 
SUPPLEMENTAL VIDEO LEGEND 
Supplemental Video. (Related to Figure 5). Three D reconstruction of a forming glomerulus in an implant 
from day 12 PSC-kidney progenitors. Note the capillary and mesangial-like cell in the core of the glomerulus. 
Table S1. (Related to Figure 4). Summary of implant experiments. 
 





# of cells 
per site 




cell mass (cm 
± S.E.) 







 20/24 1.13 ± 0.07 38.8 ± 1.2 




 29/36 0.98 ± 0.07 44.6 ± 1.2 
MAN13+LV-iRFP/Luc-






 9/32  0.61± 0.11 84.3 ± 0.2 
MAN13+LV-iRFP/Luc-






 7/20 N/A 79 ± 0.0 
MAN13+LV-iRFP/Luc-




 8/20 N/A 84 ± 0.0 
Table S2. (Related to experimental Procedures). Sequences of primers used for QPCR experiments. 
Primer Sequence 
OSR1 Fwd CTCCTCGAGATCCGGATTGAG 
Rev GTTCACTGCCTGAAGGAAGG 
T Fwd AGGTACCCAACCCTGAGGA 
 Rev GCAGGTGAGTTGTCAGAATAGGT 
MIXL1 Fwd GGTACCCCGACATCCACTT 
 Rev GCCTGTTCTGGAACCATACCT 
PAX2 Fwd GCAACCCCGCCTTACTAAT 
 Rev AACTAGTGGCGGTCATAGGC 
LHX1 Fwd ATGCAACCTGACCGAGAAGT 
 Rev CAGGTCGCTAGGGGAGATG 
SIX2 Fwd CGCCCATGTGGGTCAGTGGG 
 Rev AGCCGGGAGCGCTGTAGTCA 
HOXD11 Fwd GCCAGTGTGCTGTCGTTCCC 
 Rev CTTCCTACAGACCCCGCCGT 
HOXB7 Fwd GCCTACAAATCATCCGGCCA 
 Rev GGTTGGAAGCAAACGCACAA 
FOXD1 Fwd GACTCTGCACCAAGGGACTG 
 Rev CCTCGAGCGCGCTAACATAG 
GAPDH Fwd AGCCACATCGCTCAGACAC 
 Rev GCCCAATACGACCAAATCC 
WT1 Fwd GGCAGCACAGTGTGTGAACT 
 Rev CCAGGCACACCTGGTAGTTT 
SALL1 Fwd AGCGAAGCCTCAACATTTCCAATCC 
 Rev AATTCAAAGAACTCGGCACAGCACC 
SALL4 Fwd CAGATCCACGAGCGGACTCA 
 Rev CCCCGTGTGTCATGTAGTGA 
AQP1 Fwd ATTAACCCTGCTCGGTCCTT 
 Rev ACCCTGGAGTTGATGTCGTC 
PODXL Fwd TCATCATCACCATCGTCTGC 
 Rev CCACCTTCTTCTCCTGCATC 
AQP2 Fwd GTGCGCCGAAAATTTCCA 
 Rev CCTCGACTTCTCCTTGAAGCA 
UMOD Fwd AACATCACTGATATCTCCCTCCT 
 Rev TTGTCTCTGTCATTGAAGCCC 
PDGFRB Fwd GCCGTCAAGATGCTTAAATCC 
 Rev TATAGATGGGTCCTCCTTTGGT 
 
Table S3. (Related to experimental Procedures). Antibodies used in immunocytochemical (ICC) and 
immunohistochemical (IHC) analyses 
 
Antibody Host Source Catalogue # Application Dilution 
AQP1 Rabbit Abcam ab15080 IHC 1:500 
CD31 (PECAM) Mouse Cell Signalling 3528 IHC 1:100 
CDH1 (E-Cadherin) Mouse Abcam 76055 ICC 1:300 
    
IHC 1:1000 
Collagen IV Rabbit Abcam ab6586 IHC 1:400 
Collagen IVα3 Rat Chondrex 7076 IHC 1:400 
Cubulin Goat Santa Cruz sc-20607 IHC 1:100 
Firefly Luciferase Rabbit Abcam 21176 IHC 1:10000 
GATA3 Goat R&D Systems AF2605 ICC 1:200 
    IHC 1:200 
Human Mitochondria Mouse Millipore MAB1273 IHC 1:200 
Ki-67 Rabbit AbCam 16667 IHC 1:100 
Laminin β2 Mouse Novus Biologicals NBP2-42387 IHC 1:5000 
Nephrin Sheep R&D Systems AF4269 ICC 1:200 
    IHC 1:500 
PAX2 Rabbit Thermo-Fisher 71-6000 ICC 1:200 
    
IHC 1:400 
Podocalyxin Mouse R&D Systems MAB1658 IHC 1:200 
Podocin Rabbit Sigma P0372 ICC 1:200 
    IHC 1:500 
PDGFRB Goat R&D Systems AF385 IHC 1:100 
SIX2 Rabbit Proteintech 11561-1-AP ICC 1:200 
Synaptopodin (H-140) Rabbit Santa Cruz sc-50459 IHC 1:200 
TRPV5 Rabbit Abcam ab137028 ICC 1:200 
    IHC 1:500 
Uromodulin Rabbit Santa Cruz sc-20631 IHC 1:100 
VEGF-A Mouse R&D Systems MAB293 IHC 1:100 
WT1 Rabbit Santa Cruz sc-192 ICC 1:100 
WT1 Rabbit Calbiochem CA1026 IHC 1:1000 
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
hPSC culture and differentiation 
Stem cells were grown on 24-well or 6-well plates coated with 5 μg ml-1 recombinant human Vitronectin 
(rhVTN-N, Life Technologies, #A14700) in the case of MAN11 and MAN13 or with Matrigel BD Biosciences, 
#734-1440) in the case of HUES1, in mTeSR1 (StemCell Technologies, #5850) or TeSR2 medium (StemCell 
Technologies, #5860), with the medium changed every two days. The cells were passaged by treatment of the 
cultures with 0.5mM EDTA solution, pH8 (Invitrogen, #15575-038; diluted in PBS) and replating the cells in 
mTeSR1 or TeSR2 medium, containing 5nM ROCK inhibitor, Y-27632 (Tocris, #1254) for 24h. 
For 2D differentiation, stem cells were plated on vitronectin-coated plates, at a density of 18,000 cells cm
-2
 in 
mTeSR1 or TeSR2 medium containing 10M Y-27632. The following day the medium was replaced with 
STEMdiff™ APEL™ (StemCell Technologies, #05210), containing 8 μM CHIR-99021 (Tocris, #4423) for 
three days, followed by APEL™ supplemented with 200 ng ml−1 FGF9 (Peprotech, #100-23) and 1 μg ml−1 
heparin (Sigma, #3149) for a further 10 days. Subsequently, the cells were cultured in basal APEL™ medium 
which was changed daily. Differentiation in 3D cultures was performed according to Takasato et al (2015). 
Cells were differentiated for the first 7 days as in the 2D protocol above and then dissociated with TrypLE (Life 
Technlogies, #12605-028). Aliquots of 2.5x10
5
 cells were centrifuged at 400g for 2 min and the pellets were 
subsequently cultured on a medium-air interface by transfer onto a MilliCell cell culture insert (0.4μm pore size; 
Millipore, #PICM03050) inserted into the wells of 6-well plates. Upon transfer, the cells were exposed to 
APEL™ medium containing 5μM CHIR-99021 for 1h, before reverting back to APEL™ with FGF9/Heparin for 
a further 5 days. Finally, the 3D cultures were maintained in basal APEL™ medium for another 13 days.  
 
Immunostaining of cultures 
Cells were washed twice in PBS and then fixed in 4% paraformaldehyde (PFA) for 20 minutes, followed by 
another two PBS washes. The fixed cells were blocked and permeabilised for 30  min with 3% bovine serum 
albumin (BSA)/0.3% Triton-X in PBS before overnight incubation at 4˚C with primary antibodies (Table S3) 
diluted in 3% BSA/PBS. They were then washed three times with PBS/0.1% Triton-X, followed by Alexa-
Fluor™-488- or Alexa-Fluor™-594-labelled, species-specific secondary antibodies (Life Technologies; 1:300 
dilution in 3% BSA/PBS). Images were collected on a Zeiss Axioimager.D2 upright microscope using a 
63x/Plan-neofluar objective and captured using a Coolsnap HQ2 camera (Photometrics) through Micromanager 
software v1.4.23. Images were then processed and analysed using ImageJ (http://imagej.net/Fiji/Downloads). 
 
Construction of the lentiviral shuttle plasmid 
First, the iRFP720 coding sequence was excised from piRFP720-N1 (a gift from Vladislav Verkhusha, Addgene 
plasmid # 45461; Shcherbakova and Verkhusha, 2013) by EcoRI/XbaI digestion and was cloned into the pHIV-
Luciferase vector (a gift from Bryan Welm, Addgene plasmid # 21375), upstream of its IRES element, to obtain 
the pHIV-iRFP720-IRES-Luc plasmid. To achieve a more efficient translation of the Luciferase coding 
sequence, the IRES was then replaced with an E2A peptide motif, using a two-step PCR protocol to create the 
pHIV-iRFP720-E2A-Luc plasmid. 
To construct the 3
rd
 generation lentiviral shuttle plasmid pRRL.sin.cppt.EF1α-iRFP-E2A-Luc, the EF1α 
promoter was first extracted from the pHIV-iRFP-IRES-Luc by PCR, using primers carrying ClaI/XbaI sites at 
their ends. The PCR product was digested with these enzymes and ligated into ClaI/XbaI-digested 
pRRL.sin.cppt.CMV-EGFP-WPRE (a gift from James Uney, University of Bristol) to yield 
pRRL.sin.cppt.EF1α-EGFP-WPRE. Next, pHIV-EF1α-iRFP-E2A-Luc was digested with EcoRI/ClaI, blunt-
ended and the EF1α-iRFP-E2A-Luc-containing fragment was ligated into the BamHI/SalI-digested and blunt-
ended pRRL.sin.cppt.EF1α-EGFP-WPRE vector. 
Lentiviral vector production 
Lentiviral vectors were produced by transfection of HEK-293T cells by calcium phosphate precipitation, in 
15cm dishes, at 50% confluency, with 10μg pRRL.sin.cppt.EF1α-iRFP-E2A-Luc, 10μg pMDLg-pRRE, 3.4μg 
pMD2.G and 2μg pRSV-Rev per dish. Cell medium was collected over two days and centrifuged at 6,000g 
overnight, the pellet resuspended in PBS and the new suspension centrifuged in a SW40-Ti rotor (Beckman 
Coulter Ltd, High Wycombe, UK) at 50,000g for 90min. Finally, the resulting pellet was resuspended in PBS, at 
1:2,000 of the original medium volume. The viral titre was calculated by FACS (detecting iRFP fluorescence) 
on HEK-293T cells transduced with serial dilutions of the viral preparation. HESCs were transduced with 
lentivirus at a multiplicity of infection (MOI) of 5 IU/cell. 
Viability/Toxicity assays 
Cells were plated on vitronectin-coated 24-well plates at 3.5x10
4
 cells per well and grown for six days in 
mTeSR1 medium, replacing the medium daily. Viability/toxicity assays were then carried out using the 
ApoTox-Glo™ kit (Promega) according to the manufacturer’s instructions. Prior to the start of the assay, the 
volume of medium in the well was reduced to 200μl and 40μl of the viability/toxicity reagent were added. The 
cells were replaced in the incubator for 1h, before absorbance was measured directly from the culture plate wells 
in a GLOMAX Multi+ reader using the 400Ex/505Em (viability) and 485Em/520Ex (toxicity) filters. 
 
Implantation of hPSCs and kidney progenitor cells into immunocompromised mice 
All surgery was carried out under UK Home Office Licence (70/7838) obtained after local ethics committee 
approval. MAN13 hESCs or MAN13-derived kidney progenitors (day-12 or day-19 of the differentiation 
protocol) were collected using TrypLE (Life Technlogies, #12605-028) for one or five minutes, respectively, 
centrifuged at 200 g and resuspended in warm DMEM-F12 culture medium. Cells were then counted and 
separated into 400 μl aliquots of cold DMEM-F12 containing 6.0x106 or 1.8x107 cells, respectively. Two 
hundred μl of Matrigel (Becton Dickinson, 356231) was added to the cell suspension prior to injection into 6-





 cells, respectively) was injected subcutaneously into each of four dorsal sites per mouse, 
using a syringe fitted with a 23G needle. The first two injection sites were on the left and right shoulder blades 
and the second two injection sites, approximately 1.5 cm below each of the first two.  Prior to injection, the 
animals were anaesthetised with isoflurane gas. 
 
In vivo bioluminescence imaging of mice 
All mice were administered with 100 µL of 10 mg/kg luciferin in PBS intraperitoneally. and some mice were 
also injected with 100 µL FITC dextran intravenously. The mice were then anaesthetized using 2% isoflurane in 
O2 at 2 L/min. before being transferred to the heated imaging bed in order to maintain core temperature. From 5-
15 minutes after injection, the mice were scanned in a Biospace Lab PhotonImager Optima (Biospace Lab, 
Nesles-la-Vallée, France) with the 4D attachment to allow imaging on four sides of the mouse. Mice were culled 
approximately 1 hour after injection. 
 
Histology and immunohistochemistry 
Tissue was fixed in 4% paraformaldehyde, embedded in paraffin and sectioned at 5 µm. Sections were dewaxed 
and rehydrated, and alternate slides were stained with haematoxylin and eosin (H&E) to assess overall tissue 
architecture. Images were acquired on a 3D-Histech Pannoramic-250 microscope slide-scanner using a x20 
objective (Zeiss) and selected images were captured using the Case Viewer software (3D-Histech). After 
rehydration, other slides were boiled in an 800W microwave in 10 mM sodium citrate buffer (pH 6.0). After 
cooling to room temperature, endogenous peroxidase activity was blocked using 0.3% H2O2 in PBS for 10 
minutes. Sections were permeabilized using 0.2% Triton X-100 (Sigma-Aldrich) for 10 minutes and blocked 
using 1% bovine serum albumin (BSA) with 10% serum from the species in which the secondary antibody was 
raised. Sections were incubated overnight at 4°C with the primary antibody + 1% BSA. Primary antibodies used 
are listed in Table S3. Biotin-conjugated species specific secondary antibodies with 1% BSA were incubated at 
room temperature for 2 hours. Following PBS washes, slides were incubated in avidin-biotin enzyme complex 
(Vector Laboratories VECTASTAIN Elite ABC Reagent, PK-6100) for 1 hour at room temperature. Peroxidase 
activity was detected with the 3, 3'-diaminobenzidine (DAB) peroxidase substrate solution (Vector Laboratories, 
SK4100) in some cases with haematoxylin counterstain. Sections were dehydrated and mounted with DPX 
mounting medium and examined under a Leica DMLB 2 microscope. Negative controls omitted primary 
antibodies. For immunofluorescent imaging, anti-rabbit Alexa 488 (A11034, Thermo Fisher Scientific) and anti-
mouse Alexa 594 (A11032, Thermo Fisher Scientific) secondary antibodies and DAPI nuclear stain were used. 
Sections were mounted with Vectashield antifade mounting medium (H-1000, Vector Laboratories). 
Images were collected on a Zeiss Axioimager.D2 upright microscope and captured using a Coolsnap HQ2 
camera (Photometrics) through Micromanager software v1.4.23. Specific band pass filter sets for DAPI, FITC 
and Texas red were used to prevent bleed through from one channel to the next. Images were then processed 
and analysed using Fiji ImageJ (http://imagej.net/Fiji/Downloads).For visualisation of the FITC dextran by 
fluorescent microscopy, dewaxed and rehydrated paraffin embedded sections were mounted with Vectashield 
antifade mounting medium. Images were acquired on an Olympus IX83 inverted microscope. The images were 
collected using a R6 CCD camera with a Z optical spacing of 0.2μm. Raw images were then deconvolved using 
the Huygens Pro software (SVI). 
Transmission electron microscopy and serial block face-scanning electron microscopy 
Organoid implants were cut into 1 mm cubes and fixed in situ by using 2% (wt/vol) glutaraldehyde (Agar 
Scientific, UK) in 0.1 M cacodylate buffer (pH 7.2); stained in 1% (wt/vol) osmium tetroxide, 1.5% (wt/vol) 
potassium ferrocyanide in 0.1 M cacodylate buffer, followed by 1 % (wt/vol) thiocarbohydrazide. After they 
were stained further in 1% (wt/vol) osmium tetroxide, and soaked in 1% (wt/vol) uranyl acetate overnight. In the 
final staining step incubation was performed at 60
o
C with lead aspartate pH 5.5 for one hour (Starborg et al., 
2013). Samples were dehydrated in ethanol, infiltrated in TAAB 812 hard resin and sectioned at 70-80nm 
thickness. Sections were examined using a FEI Tecnai 12G2 Biotwin transmission electron microscope at 
magnification from 145X to 6800X. For Serial Block face scanning electon microscopy following preparation as 
above the block was placed in the Quanta 250 FEG (FEI Company) + Gatan 3view system and a 41 μm × 41 μm 
field of view was chosen and imaged by using a 4096 × 4096 scan, which gave an approximate pixel size of 
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